Your SlideShare is downloading. ×
  • Like
Joshua Holzer - How to dodge common pitfalls leading to prosecution in the pharma industry
Upcoming SlideShare
Loading in...5
×

Thanks for flagging this SlideShare!

Oops! An error has occurred.

×

Now you can save presentations on your phone or tablet

Available for both IPhone and Android

Text the download link to your phone

Standard text messaging rates apply

Joshua Holzer - How to dodge common pitfalls leading to prosecution in the pharma industry

  • 357 views
Published

Joshua Holzer, Chief Compliance Counsel for Global Trade, Pfizer Inc, joins Pharma IQ to discuss common concerns of pharma companies when it comes to compliance regulatory investigations and …

Joshua Holzer, Chief Compliance Counsel for Global Trade, Pfizer Inc, joins Pharma IQ to discuss common concerns of pharma companies when it comes to compliance regulatory investigations and strategies that in house counsel can use to help their company protect itself and better manage compliance

Published in Business , Economy & Finance
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Be the first to comment
    Be the first to like this
No Downloads

Views

Total Views
357
On SlideShare
0
From Embeds
0
Number of Embeds
0

Actions

Shares
Downloads
0
Comments
0
Likes
0

Embeds 0

No embeds

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
    No notes for slide

Transcript

  • 1. How to dodge common pitfalls leading to prosecution in the pharma industry Interview by Helen Winsor, Pharma IQ Joshua Holzer, Chief Compliance Counsel for Global Trade, Pfizer Inc, joins Pharma IQ to discuss common concerns of pharma companies when it comes to compliance regulatory investigations and strategies that in house counsel can use to help their company protect itself and better manage compliancePharma IQ: In this new heightened risk management environment, what are you seeing asthe most common concerns of pharma companies when it comes to compliance regulatoryinvestigations?J Holzer: Like in past years, potential corruption involving government officials as well aspromotion and marketing activities really are popular areas of concern for pharma companiesand companies worldwide in general. With the global nature of commerce though andincreased compliance in global trade areas companies are increasingly looking at their levelof compliance with global trade laws, and that’s import laws and export laws and certainly thesanctions and embargoes area with all of the changes after last year’s involvement of all theMiddle East and Northern African countries in changes in political structure and restrictedparties. And they’re putting resources towards dealing with those areas and they’reparticularly important because they’re really complex and in-depth and the laws do changefrom country to country and they should be harmonised but they’re not necessarily that way.Pharma IQ: What do you feel are the most common pitfalls in the pharma industry that canlead to prosecution?To download this interview in full please click here: http://bit.ly/IQLlP6Joshua Holzer will be speaking at the Information Governance & eDiscovery for Pharma,Biotech and Medical Devices conference, taking place 26 - 28 June 2012 in Munich,Germany. For information please visit: www.pharmaediscovery.com/, contact us on 0800 6522363 or +44 (0) 20 7368 9300 or email enquire@iqpc.co.uk.IQPCPlease note that we do all we can to ensure accuracy within the translation to word of audio interviews but that errors may stillunderstandably occur in some cases. If you believe that a serious inaccuracy has been made within the text, please contact +44(0) 207 368 9425 or email helen.winsor@iqpc.co.uk. 1